Research studies are clinical trials where interventions in human subjects – such as a new medicine, procedure, process or device; or a new application of an existing medicine, process or device – are tested. They are an important method for providing evidence-based information for treatments, as well as identifying new ways to detect, diagnose, prevent or reduce the risk of serious diseases and chronic illness.
Trava Health Clinic has collaborated with The Quality of Life Evaluation Study (QUEST Initiative), conducted by researchers at the University of Sydney, which aimed to be the world’s largest longitudinal clinical study investigating the quality of life and health economic impact of flower-derived treatments on patients with chronic disease. Patients accessing flower-derived treatment generally have a range of conditions and symptoms that impact their quality of life. This clinical study was set out to better understand and measure how these conditions and symptoms affect patients’ quality of life over time while they were accessing flower-derived treatments as an option.
We also continue to collaborate with Medlab regarding research into pain management using flower-derived treatment therapies. At Trava Health we believe that high quality clinical trials can deliver information in crucial areas that will benefit the Australian patient market and are therefore committed to future collaborations with reputable researchers. To find out more, ask our specialist plant medicine care consultants or visit the relevant websites.
There are several clinical trials of cannabis medicines underway across Australia exploring new and improved treatments, devices and products. Clinical trials must be registered on the Australian New Zealand Clinical Trials Registry. Information about clinical trials underway internationally can be found at:
